FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2460147600> ?p ?o ?g. }

• W2460147600 endingPage "41" @default.
• W2460147600 startingPage "36" @default.
• W2460147600 abstract "The development of inhibitors to factor VIII (FVIII) or factor IX (FIX) remains a major treatment complication encountered in the treatment of haemophilia. Not all patients with even the same severity and genotype develop inhibitors suggesting an underlying mechanism of tolerance against FVIII- or FIX-related immunity. One mechanism may be central tolerance observed in patients in whom the FVIII mutation enables some production of the protein. The other is a peripheral tolerance mechanism which may be evident in patients with null mutation. Recently, recombinant porcine FVIII (rpFVIII, Obixur, OBI-1, BAX801) has been developed for the haemostatic treatment of both congenital haemophilia with inhibitor (CHAWI) and acquired haemophilia A (AHA). In 28 subjects with AHA with life-/limb-threatening bleeding, rpFVIII reduced or stopped bleeding in all patients within 24 h. The cross-reactivity of anti-human FVIII antibodies to rpFVIII remains around 30–50%. Recently, new therapeutics based on the quite novel concepts have been developed and clinical studies are ongoing. These are humanized asymmetric antibody mimicking FVIIIa function by maintaining a suitable interaction between FIXa and FX (Emicizumab, ACE910), and small interfering RNAs (siRNA, ALN-AT3) suppress liver production of AT through post-transcriptional gene silencing and a humanized anti-TFPI monoclonal antibody (Concizumab). Their main advantages are longer half-life, subcutaneous applicability and efficacy irrespective of the presence of inhibitors which will make it easier to initiate more effective treatment especially early childhood." @default.
• W2460147600 created "2016-07-22" @default.
• W2460147600 creator A5017307924 @default.
• W2460147600 creator A5061703162 @default.
• W2460147600 creator A5086373140 @default.
• W2460147600 date "2016-07-01" @default.
• W2460147600 modified "2023-10-16" @default.
• W2460147600 title "Alternative therapies for the management of inhibitors" @default.
• W2460147600 cites W1484389177 @default.
• W2460147600 cites W1492340463 @default.
• W2460147600 cites W1681554733 @default.
• W2460147600 cites W1765612628 @default.
• W2460147600 cites W1963967196 @default.
• W2460147600 cites W1991223023 @default.
• W2460147600 cites W1998614164 @default.
• W2460147600 cites W2019295834 @default.
• W2460147600 cites W2026336161 @default.
• W2460147600 cites W2027319450 @default.
• W2460147600 cites W2028315628 @default.
• W2460147600 cites W2032093921 @default.
• W2460147600 cites W2041235125 @default.
• W2460147600 cites W2051253171 @default.
• W2460147600 cites W2067687662 @default.
• W2460147600 cites W2072864431 @default.
• W2460147600 cites W2086294372 @default.
• W2460147600 cites W2087435777 @default.
• W2460147600 cites W2106536550 @default.
• W2460147600 cites W2143090141 @default.
• W2460147600 cites W2151826104 @default.
• W2460147600 cites W2169013901 @default.
• W2460147600 cites W2278365462 @default.
• W2460147600 cites W2400928773 @default.
• W2460147600 cites W2494708045 @default.
• W2460147600 cites W2504686900 @default.
• W2460147600 cites W2518847837 @default.
• W2460147600 cites W2583121661 @default.
• W2460147600 cites W2979417036 @default.
• W2460147600 cites W4256252711 @default.
• W2460147600 doi "https://doi.org/10.1111/hae.13005" @default.
• W2460147600 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27405674" @default.
• W2460147600 hasPublicationYear "2016" @default.
• W2460147600 type Work @default.
• W2460147600 sameAs 2460147600 @default.
• W2460147600 citedByCount "21" @default.
• W2460147600 countsByYear W24601476002016 @default.
• W2460147600 countsByYear W24601476002017 @default.
• W2460147600 countsByYear W24601476002018 @default.
• W2460147600 countsByYear W24601476002019 @default.
• W2460147600 countsByYear W24601476002020 @default.
• W2460147600 countsByYear W24601476002021 @default.
• W2460147600 countsByYear W24601476002022 @default.
• W2460147600 countsByYear W24601476002023 @default.
• W2460147600 crossrefType "journal-article" @default.
• W2460147600 hasAuthorship W2460147600A5017307924 @default.
• W2460147600 hasAuthorship W2460147600A5061703162 @default.
• W2460147600 hasAuthorship W2460147600A5086373140 @default.
• W2460147600 hasBestOaLocation W24601476001 @default.
• W2460147600 hasConcept C104317684 @default.
• W2460147600 hasConcept C111472728 @default.
• W2460147600 hasConcept C119056186 @default.
• W2460147600 hasConcept C138885662 @default.
• W2460147600 hasConcept C159654299 @default.
• W2460147600 hasConcept C187212893 @default.
• W2460147600 hasConcept C203014093 @default.
• W2460147600 hasConcept C2777232031 @default.
• W2460147600 hasConcept C2777702733 @default.
• W2460147600 hasConcept C2778385053 @default.
• W2460147600 hasConcept C501734568 @default.
• W2460147600 hasConcept C542903549 @default.
• W2460147600 hasConcept C54355233 @default.
• W2460147600 hasConcept C60644358 @default.
• W2460147600 hasConcept C71924100 @default.
• W2460147600 hasConcept C86803240 @default.
• W2460147600 hasConcept C8891405 @default.
• W2460147600 hasConcept C89611455 @default.
• W2460147600 hasConceptScore W2460147600C104317684 @default.
• W2460147600 hasConceptScore W2460147600C111472728 @default.
• W2460147600 hasConceptScore W2460147600C119056186 @default.
• W2460147600 hasConceptScore W2460147600C138885662 @default.
• W2460147600 hasConceptScore W2460147600C159654299 @default.
• W2460147600 hasConceptScore W2460147600C187212893 @default.
• W2460147600 hasConceptScore W2460147600C203014093 @default.
• W2460147600 hasConceptScore W2460147600C2777232031 @default.
• W2460147600 hasConceptScore W2460147600C2777702733 @default.
• W2460147600 hasConceptScore W2460147600C2778385053 @default.
• W2460147600 hasConceptScore W2460147600C501734568 @default.
• W2460147600 hasConceptScore W2460147600C542903549 @default.
• W2460147600 hasConceptScore W2460147600C54355233 @default.
• W2460147600 hasConceptScore W2460147600C60644358 @default.
• W2460147600 hasConceptScore W2460147600C71924100 @default.
• W2460147600 hasConceptScore W2460147600C86803240 @default.
• W2460147600 hasConceptScore W2460147600C8891405 @default.
• W2460147600 hasConceptScore W2460147600C89611455 @default.
• W2460147600 hasFunder F4320306923 @default.
• W2460147600 hasFunder F4320307765 @default.
• W2460147600 hasFunder F4320307771 @default.
• W2460147600 hasFunder F4320307779 @default.
• W2460147600 hasFunder F4320308604 @default.

• next